Literature DB >> 15741528

Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial.

Gregg W Stone1, John Webb, David A Cox, Bruce R Brodie, Mansoor Qureshi, Anna Kalynych, Mark Turco, Heinz P Schultheiss, Daniel Dulas, Barry D Rutherford, David Antoniucci, Mitchell W Krucoff, Raymond J Gibbons, Denise Jones, Alexandra J Lansky, Roxana Mehran.   

Abstract

CONTEXT: Atheromatous and thrombotic embolization during percutaneous coronary intervention (PCI) in acute myocardial infarction is common and may result in microcirculatory dysfunction, the prevention of which may improve reperfusion success, reduce infarct size, and enhance event-free survival.
OBJECTIVE: To determine whether protection of the distal microcirculation from thromboembolic debris liberated during primary PCI results in improved reperfusion and decreased infarct size. DESIGN, SETTING, AND PATIENTS: Prospective randomized controlled trial at 38 academic and community-based institutions in 7 countries enrolling 501 patients aged 18 years or older with ST-segment elevation myocardial infarction (STEMI) presenting within 6 hours of symptom onset and undergoing primary PCI or rescue intervention after failed thrombolysis.
INTERVENTIONS: Patients were randomized between May 20, 2002, and November 21, 2003, to receive PCI with a balloon occlusion and aspiration distal microcirculatory protection system vs angioplasty without distal protection. MAIN OUTCOME MEASURES: Coprimary end points were ST-segment resolution (STR) measured 30 minutes after PCI by continuous Holter monitoring and infarct size measured by technetium Tc 99m sestamibi imaging between days 5 and 14. Secondary end points included major adverse cardiac events.
RESULTS: Among 252 patients assigned to distal protection, aspiration was performed in 97% (242/251), all angioplasty balloon inflations were fully protected in 79% (193/245), and visible debris was retrieved from 73% (182/250). Complete STR was achieved in a similar proportion reperfused with vs without distal protection (63.3% [152/240] vs 61.9% [148/239], respectively; absolute difference, 1.4% [95% confidence interval, -7.7% to 10.5%; P = .78]), and left ventricular infarct size was similar in both groups (median, 12.0% [n = 229] vs 9.5% [n = 208], respectively; P = .15). Major adverse cardiac events at 6 months occurred with similar frequency in the distal protection and control groups (10.0% vs 11.0%, respectively; P = .66).
CONCLUSIONS: A distal balloon occlusion and aspiration system effectively retrieves embolic debris in most patients with acute STEMI undergoing emergent PCI. Nonetheless, distal embolic protection did not result in improved microvascular flow, greater reperfusion success, reduced infarct size, or enhanced event-free survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741528     DOI: 10.1001/jama.293.9.1063

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  83 in total

1.  The role of von Willebrand factor and ADAMTS13 in the no-reflow phenomenon: after primary percutaneous coronary intervention.

Authors:  Bilian Zhao; Jian Li; Xinping Luo; Qing Zhou; Hua Chen; Haiming Shi
Journal:  Tex Heart Inst J       Date:  2011

Review 2.  Stenting of complex lesions: an overview.

Authors:  Usman Baber; Annapoorna S Kini; Samin K Sharma
Journal:  Nat Rev Cardiol       Date:  2010-09       Impact factor: 32.419

3.  Treatment of a large thrombus containing lesion with the MGuard protective net coronary stent system: optical coherence tomographic evidence of complete plaque sealing.

Authors:  Alessio La Manna; Salvatore Davide Tomasello; Corrado Tamburino
Journal:  Clin Res Cardiol       Date:  2010-06-30       Impact factor: 5.460

Review 4.  Thrombectomy during primary angioplasty: methods, devices, and clinical trial data.

Authors:  Giuseppe De Luca; Monica Verdoia; Ettore Cassetti
Journal:  Curr Cardiol Rep       Date:  2010-09       Impact factor: 2.931

5.  Frequency and prognostic impact of intravascular imaging-guided urgent percutaneous coronary intervention in patients with acute myocardial infarction: results from J-MINUET.

Authors:  Hiroyuki Okura; Yoshihiko Saito; Tsunenari Soeda; Koichi Nakao; Yukio Ozaki; Kazuo Kimura; Junya Ako; Teruo Noguchi; Satoshi Yasuda; Satoru Suwa; Kazuteru Fujimoto; Yasuharu Nakama; Takashi Morita; Wataru Shimizu; Atsushi Hirohata; Yasuhiro Morita; Teruo Inoue; Atsunori Okamura; Masaaki Uematsu; Kazuhito Hirata; Kengo Tanabe; Yoshisato Shibata; Mafumi Owa; Kenichi Tsujita; Kunihiro Nishimura; Yoshihiro Miyamoto; Masaharu Ishihara
Journal:  Heart Vessels       Date:  2018-11-02       Impact factor: 2.037

Review 6.  Recent advances in primary percutaneous intervention for acute myocardial infarction.

Authors:  E J Smith; A Mathur; M T Rothman
Journal:  Heart       Date:  2005-12       Impact factor: 5.994

Review 7.  Infarct angioplasty: beyond stents and glycoprotein IIb/IIIa inhibitors.

Authors:  S R Dixon
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

Review 8.  The pathology of myocardial infarction in the pre- and post-interventional era.

Authors:  M Pasotti; F Prati; E Arbustini
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

Review 9.  Role of Sam68 as an adaptor protein in signal transduction.

Authors:  S Najib; C Martín-Romero; C González-Yanes; V Sánchez-Margalet
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

10.  Differential effects of post-dilation after stent deployment in patients presenting with and without acute myocardial infarction.

Authors:  Zhi-Jiang Zhang; Oscar C Marroquin; Roslyn A Stone; Joel L Weissfeld; Suresh R Mulukutla; Faith Selzer; Kevin E Kip
Journal:  Am Heart J       Date:  2010-11       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.